Only sarcoma patients with high expression levels of IL18, NLRP2, PYCARD, and TNF genes had favourable clinical outcomes, implicating that these PRGs are possible biomarkers of protective pyroptosis in sarcoma (Figures 2(a)–2(d)). Here, IL18 is linked to sarcoma.